Adjuvant treatment for melanoma in clinical practice – Trial versus reality

Melissa M. de Meza*, Rawa K. Ismail, Daan Rauwerdink, Olivier J. van Not, Jesper van Breeschoten, Willeke A.M. Blokx, Anthonius de Boer, Maaike van Dartel, Doranne L. Hilarius, Eva Ellebaek, Han J. Bonenkamp, Christian U. Blank, Maureen J.B. Aarts, Alexander C.J. van Akkooi, Franchette W.P.J. van den Berkmortel, Marye J. Boers-Sonderen, Jan Willem B. de Groot, John B. Haanen, Geke A.P. Hospers, Ellen W. KapiteijnDjura Piersma, Roos S. van Rijn, Astrid A.M. van der Veldt, Art Vreugdenhil, Hans M. Westgeest, Alfons J.M. van den Eertwegh, Karijn P.M. Suijkerbuijk, Michel W.J.M. Wouters

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

12 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Adjuvant treatment for melanoma in clinical practice – Trial versus reality'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science